| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L-ascorbic acid transmembrane transporter activity | 5.91e-05 | 2 | 154 | 2 | GO:0015229 | |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 5.91e-05 | 2 | 154 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | L-ascorbate:sodium symporter activity | 5.91e-05 | 2 | 154 | 2 | GO:0008520 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.65e-04 | 36 | 154 | 4 | GO:0090482 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 3.37e-04 | 18 | 154 | 3 | GO:0035014 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC44A4 SLC2A3 SLC4A2 SLC6A7 SLC16A4 SLC16A3 SLC51A SLC23A2 SLC23A1 | 4.62e-04 | 293 | 154 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC44A4 SLC4A2 SLC6A7 CLCN6 SLC16A4 SLC16A3 SLC18A3 SLC23A2 SLC23A1 | 4.97e-04 | 296 | 154 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 5.82e-04 | 5 | 154 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | netrin receptor activity | 8.69e-04 | 6 | 154 | 2 | GO:0005042 | |
| GeneOntologyCellularComponent | INO80-type complex | 5.58e-05 | 28 | 158 | 4 | GO:0097346 | |
| GeneOntologyCellularComponent | Ino80 complex | 2.67e-04 | 17 | 158 | 3 | GO:0031011 | |
| Domain | TF_fork_head_CS_2 | 3.61e-05 | 46 | 153 | 5 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 4.02e-05 | 47 | 153 | 5 | IPR018122 | |
| Domain | FH | 4.93e-05 | 49 | 153 | 5 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.93e-05 | 49 | 153 | 5 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.93e-05 | 49 | 153 | 5 | PS00658 | |
| Domain | Fork_head_dom | 4.93e-05 | 49 | 153 | 5 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.93e-05 | 49 | 153 | 5 | PS50039 | |
| Domain | Forkhead | 4.93e-05 | 49 | 153 | 5 | PF00250 | |
| Domain | ZU5 | 6.20e-05 | 10 | 153 | 3 | PS51145 | |
| Domain | DUOX1 | 6.67e-05 | 2 | 153 | 2 | IPR029595 | |
| Domain | ZU5 | 1.12e-04 | 12 | 153 | 3 | PF00791 | |
| Domain | ZU5_dom | 1.12e-04 | 12 | 153 | 3 | IPR000906 | |
| Domain | uDENN | 1.84e-04 | 14 | 153 | 3 | SM00800 | |
| Domain | Xan_ur_permease | 1.99e-04 | 3 | 153 | 2 | PF00860 | |
| Domain | Xant/urac/vitC | 1.99e-04 | 3 | 153 | 2 | IPR006043 | |
| Domain | Keratin_matx | 1.99e-04 | 3 | 153 | 2 | PF04579 | |
| Domain | Orai-1 | 1.99e-04 | 3 | 153 | 2 | PF07856 | |
| Domain | CRAC_channel | 1.99e-04 | 3 | 153 | 2 | IPR012446 | |
| Domain | Stereocilin-rel | 1.99e-04 | 3 | 153 | 2 | IPR026664 | |
| Domain | uDENN | 2.28e-04 | 15 | 153 | 3 | PF03456 | |
| Domain | CAP | 2.28e-04 | 15 | 153 | 3 | PF00188 | |
| Domain | SCP | 2.28e-04 | 15 | 153 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 2.28e-04 | 15 | 153 | 3 | IPR001283 | |
| Domain | - | 2.28e-04 | 15 | 153 | 3 | 3.40.33.10 | |
| Domain | CAP_domain | 2.28e-04 | 15 | 153 | 3 | IPR014044 | |
| Domain | DENN | 2.79e-04 | 16 | 153 | 3 | SM00799 | |
| Domain | DENN | 2.79e-04 | 16 | 153 | 3 | PF02141 | |
| Domain | dDENN | 2.79e-04 | 16 | 153 | 3 | PF03455 | |
| Domain | UDENN | 2.79e-04 | 16 | 153 | 3 | PS50946 | |
| Domain | DDENN | 2.79e-04 | 16 | 153 | 3 | PS50947 | |
| Domain | dDENN | 2.79e-04 | 16 | 153 | 3 | SM00801 | |
| Domain | dDENN_dom | 2.79e-04 | 16 | 153 | 3 | IPR005112 | |
| Domain | uDENN_dom | 2.79e-04 | 16 | 153 | 3 | IPR005113 | |
| Domain | DENN | 2.79e-04 | 16 | 153 | 3 | PS50211 | |
| Domain | DENN_dom | 2.79e-04 | 16 | 153 | 3 | IPR001194 | |
| Domain | Tscrpt_reg_SKI_SnoN | 3.96e-04 | 4 | 153 | 2 | IPR023216 | |
| Domain | c-SKI_SMAD_bind | 3.96e-04 | 4 | 153 | 2 | PF08782 | |
| Domain | Keratin_matx | 3.96e-04 | 4 | 153 | 2 | PD010562 | |
| Domain | c-SKI_SMAD_bind | 3.96e-04 | 4 | 153 | 2 | SM01046 | |
| Domain | c-SKI_SMAD4-bd_dom | 3.96e-04 | 4 | 153 | 2 | IPR014890 | |
| Domain | Keratin_matx | 6.56e-04 | 5 | 153 | 2 | IPR007659 | |
| Domain | UPA | 6.56e-04 | 5 | 153 | 2 | PF17217 | |
| Domain | UPA | 6.56e-04 | 5 | 153 | 2 | IPR033772 | |
| Domain | Ig_I-set | 9.81e-04 | 190 | 153 | 7 | IPR013098 | |
| Domain | I-set | 9.81e-04 | 190 | 153 | 7 | PF07679 | |
| Domain | Notch_dom | 1.36e-03 | 7 | 153 | 2 | IPR000800 | |
| Domain | NAD_binding_6 | 1.36e-03 | 7 | 153 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.36e-03 | 7 | 153 | 2 | PF08022 | |
| Domain | Notch | 1.36e-03 | 7 | 153 | 2 | PF00066 | |
| Domain | Ski_Sno | 1.36e-03 | 7 | 153 | 2 | PF02437 | |
| Domain | - | 1.36e-03 | 7 | 153 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 1.36e-03 | 7 | 153 | 2 | IPR003380 | |
| Domain | FAD-bd_8 | 1.36e-03 | 7 | 153 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.36e-03 | 7 | 153 | 2 | IPR013121 | |
| Domain | NL | 1.36e-03 | 7 | 153 | 2 | SM00004 | |
| Domain | DEATH | 1.36e-03 | 27 | 153 | 3 | SM00005 | |
| Domain | MFS | 1.96e-03 | 108 | 153 | 5 | PS50850 | |
| Domain | PAS | 2.25e-03 | 32 | 153 | 3 | SM00091 | |
| Domain | ZU5 | 2.31e-03 | 9 | 153 | 2 | SM00218 | |
| Domain | Death | 2.46e-03 | 33 | 153 | 3 | PF00531 | |
| Domain | PAS | 2.68e-03 | 34 | 153 | 3 | PS50112 | |
| Domain | PAS | 2.68e-03 | 34 | 153 | 3 | IPR000014 | |
| Domain | An_peroxidase | 2.87e-03 | 10 | 153 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.87e-03 | 10 | 153 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 2.87e-03 | 10 | 153 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 2.87e-03 | 10 | 153 | 2 | PS50292 | |
| Domain | - | 2.87e-03 | 10 | 153 | 2 | 1.10.640.10 | |
| Domain | DNA-bd_dom_put | 3.49e-03 | 11 | 153 | 2 | IPR009061 | |
| Domain | Death_domain | 3.69e-03 | 38 | 153 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 3.69e-03 | 38 | 153 | 3 | PS50017 | |
| Domain | MFS_1 | 3.69e-03 | 77 | 153 | 4 | PF07690 | |
| Domain | MFS | 3.69e-03 | 77 | 153 | 4 | IPR011701 | |
| Domain | Ferric_reduct | 4.17e-03 | 12 | 153 | 2 | PF01794 | |
| Domain | - | 4.17e-03 | 12 | 153 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 4.17e-03 | 12 | 153 | 2 | IPR010919 | |
| Domain | Fe3_Rdtase_TM_dom | 4.17e-03 | 12 | 153 | 2 | IPR013130 | |
| Domain | MFS_dom | 4.95e-03 | 134 | 153 | 5 | IPR020846 | |
| Domain | C-type_lectin_CS | 5.23e-03 | 43 | 153 | 3 | IPR018378 | |
| Domain | IG | 7.97e-03 | 421 | 153 | 9 | SM00409 | |
| Domain | Ig_sub | 7.97e-03 | 421 | 153 | 9 | IPR003599 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 3.35e-05 | 8 | 121 | 3 | M27091 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 4.99e-05 | 9 | 121 | 3 | MM14769 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.68e-05 | 11 | 121 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.28e-04 | 12 | 121 | 3 | MM1526 | |
| Pubmed | 2.49e-09 | 13 | 161 | 5 | 7957066 | ||
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 6.59e-09 | 6 | 161 | 4 | 27092474 | |
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 3.05e-08 | 8 | 161 | 4 | 8530406 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 5.47e-08 | 9 | 161 | 4 | 12412011 | |
| Pubmed | Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. | 7.91e-08 | 24 | 161 | 5 | 11820816 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 9.74e-08 | 3 | 161 | 3 | 26170455 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 9.74e-08 | 3 | 161 | 3 | 33603190 | |
| Pubmed | Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex. | 1.21e-07 | 26 | 161 | 5 | 15857913 | |
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 3.06e-07 | 13 | 161 | 4 | 16884697 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 16709836 | ||
| Pubmed | The type of DUOX-dependent ROS production is dictated by defined sequences in DUOXA. | 3.88e-07 | 4 | 161 | 3 | 22814254 | |
| Pubmed | Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. | 3.88e-07 | 4 | 161 | 3 | 19339556 | |
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 5.80e-07 | 15 | 161 | 4 | 7689224 | |
| Pubmed | 5.80e-07 | 15 | 161 | 4 | 22045912 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 7.71e-07 | 16 | 161 | 4 | 8861101 | |
| Pubmed | 7.71e-07 | 16 | 161 | 4 | 10208738 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 12234674 | ||
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 1.62e-06 | 19 | 161 | 4 | 9895322 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 18668520 | ||
| Pubmed | 2.02e-06 | 20 | 161 | 4 | 12812790 | ||
| Pubmed | PGS1 C12orf56 CAMSAP3 PEX6 GON4L C15orf39 SLC4A2 PRR12 MARF1 PAM YY1AP1 DNA2 DDX11L8 LRRC41 | 2.24e-06 | 650 | 161 | 14 | 38777146 | |
| Pubmed | 2.49e-06 | 21 | 161 | 4 | 9449667 | ||
| Pubmed | 3.03e-06 | 22 | 161 | 4 | 17389379 | ||
| Pubmed | 4.37e-06 | 24 | 161 | 4 | 29992973 | ||
| Pubmed | 9.60e-06 | 29 | 161 | 4 | 22972626 | ||
| Pubmed | Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. | 1.14e-05 | 10 | 161 | 3 | 18194653 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 2.13e-05 | 2 | 161 | 2 | 28633507 | |
| Pubmed | Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. | 2.13e-05 | 2 | 161 | 2 | 19887627 | |
| Pubmed | Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus. | 2.13e-05 | 2 | 161 | 2 | 18261624 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10395795 | ||
| Pubmed | Complex formation between proteins encoded by the ski gene family. | 2.13e-05 | 2 | 161 | 2 | 8514802 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 26445441 | ||
| Pubmed | N-Glycosylation is required for Na+-dependent vitamin C transporter functionality. | 2.13e-05 | 2 | 161 | 2 | 18619416 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18791929 | ||
| Pubmed | Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus. | 2.13e-05 | 2 | 161 | 2 | 22449796 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 28177761 | ||
| Pubmed | Communication between N terminus and loop2 tunes Orai activation. | 2.13e-05 | 2 | 161 | 2 | 29237733 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 2.13e-05 | 2 | 161 | 2 | 22523549 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16357110 | ||
| Pubmed | Isolation of human cDNA clones of ski and the ski-related gene, sno. | 2.13e-05 | 2 | 161 | 2 | 2762147 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34822124 | ||
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 2.13e-05 | 2 | 161 | 2 | 23281318 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18247577 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11101640 | ||
| Pubmed | Proto-oncogene Sno expression, alternative isoforms and immediate early serum response. | 2.13e-05 | 2 | 161 | 2 | 9207045 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31706280 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10631088 | ||
| Pubmed | Newly identified Gon4l/Udu-interacting proteins implicate novel functions. | 2.13e-05 | 2 | 161 | 2 | 32848183 | |
| Pubmed | When an Intramolecular Disulfide Bridge Governs the Interaction of DUOX2 with Its Partner DUOXA2. | 2.13e-05 | 2 | 161 | 2 | 25761904 | |
| Pubmed | A family of mammalian Na+-dependent L-ascorbic acid transporters. | 2.13e-05 | 2 | 161 | 2 | 10331392 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27349010 | ||
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 2.13e-05 | 2 | 161 | 2 | 15972824 | |
| Pubmed | The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. | 2.13e-05 | 2 | 161 | 2 | 33864850 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31513783 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34599650 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23362256 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19144650 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31044655 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21733302 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23555679 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23613229 | ||
| Pubmed | Vitamin C transporter gene polymorphisms, dietary vitamin C and serum ascorbic acid. | 2.13e-05 | 2 | 161 | 2 | 20588054 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11762710 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11832207 | ||
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 2.13e-05 | 2 | 161 | 2 | 11822874 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18417304 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20471816 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17374849 | ||
| Pubmed | Gender and sodium-ascorbate transporter isoforms determine ascorbate concentrations in mice. | 2.13e-05 | 2 | 161 | 2 | 15333707 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18177232 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34780525 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18420579 | ||
| Pubmed | SKI controls MDS-associated chronic TGF-β signaling, aberrant splicing, and stem cell fitness. | 2.13e-05 | 2 | 161 | 2 | 30249787 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20395295 | ||
| Pubmed | TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis. | 2.13e-05 | 2 | 161 | 2 | 19096149 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18782659 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36310070 | ||
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 2.13e-05 | 2 | 161 | 2 | 12824283 | |
| Pubmed | SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. | 2.13e-05 | 2 | 161 | 2 | 8233802 | |
| Pubmed | Congenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families. | 2.13e-05 | 2 | 161 | 2 | 30375286 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24492313 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19216494 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22348976 | ||
| Pubmed | The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis. | 2.13e-05 | 2 | 161 | 2 | 20530203 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10556521 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19243932 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 32425884 | ||
| Pubmed | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. | 2.13e-05 | 2 | 161 | 2 | 10806195 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11514595 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10471399 | ||
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 2.13e-05 | 2 | 161 | 2 | 24161126 | |
| Pubmed | Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. | 2.13e-05 | 2 | 161 | 2 | 15993839 | |
| Pubmed | Compound Heterozygous Mutations in the DUOX2/DUOXA2 Genes Cause Congenital Hypothyroidism. | 2.13e-05 | 2 | 161 | 2 | 28541007 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24815519 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22592922 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27932501 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 11443211 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24574459 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10601291 | ||
| Cytoband | 9q21.11 | 3.72e-06 | 30 | 161 | 4 | 9q21.11 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.06e-05 | 161 | 116 | 7 | 593 | |
| GeneFamily | ORAI calcium release-activated calcium modulators | 1.22e-04 | 3 | 116 | 2 | 668 | |
| GeneFamily | Solute carriers | SLC44A4 SLC2A3 SLC4A2 SLC6A7 SLC16A4 SLC16A3 SLC18A3 SLC51A SLC23A2 SLC23A1 | 2.30e-04 | 395 | 116 | 10 | 752 |
| GeneFamily | SKI transcriptional corepressors | 2.43e-04 | 4 | 116 | 2 | 748 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 5.34e-04 | 25 | 116 | 3 | 504 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-08 | 190 | 160 | 9 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DDR1 DHRS3 ABCA13 TMPRSS4 DUOX2 SLC44A4 DENND2B DUOX1 DENND2C | 4.38e-08 | 198 | 160 | 9 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 108 | 160 | 6 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 108 | 160 | 6 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.70e-06 | 184 | 160 | 7 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-06 | 185 | 160 | 7 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-06 | 185 | 160 | 7 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.41e-06 | 188 | 160 | 7 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 5.60e-06 | 189 | 160 | 7 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.00e-06 | 191 | 160 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.00e-06 | 191 | 160 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 194 | 160 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.65e-06 | 194 | 160 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.87e-06 | 195 | 160 | 7 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.59e-06 | 198 | 160 | 7 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-06 | 198 | 160 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.85e-06 | 199 | 160 | 7 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.11e-06 | 200 | 160 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.11e-06 | 200 | 160 | 7 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.11e-06 | 200 | 160 | 7 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | c58a5dc0a0d74a21ca15ee8b7a0197de32afa045 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.11e-06 | 200 | 160 | 7 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 85 | 160 | 5 | 159b3ac93490c3e4918ea61f8ede7add9e63ca40 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.31e-05 | 158 | 160 | 6 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 162 | 160 | 6 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 162 | 160 | 6 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.95e-05 | 165 | 160 | 6 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 3.27e-05 | 168 | 160 | 6 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-05 | 171 | 160 | 6 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-05 | 171 | 160 | 6 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 3.73e-05 | 172 | 160 | 6 | 64928cea7e5b60e4bc4af016454b0173ebcc07c7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.10e-05 | 175 | 160 | 6 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-05 | 177 | 160 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.37e-05 | 177 | 160 | 6 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 177 | 160 | 6 | 5f20a1a875d6f85ec07b097e6afdb07c2f8f88ff | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 179 | 160 | 6 | 7aa4137f672dadb3be92009cde6e0ea60a15372d | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.11e-05 | 182 | 160 | 6 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.11e-05 | 188 | 160 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | IPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | ad7bb3a7de8e48c145e4382f90d30bb2159c2b76 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.29e-05 | 189 | 160 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 189 | 160 | 6 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 6.48e-05 | 190 | 160 | 6 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 6.48e-05 | 190 | 160 | 6 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.67e-05 | 191 | 160 | 6 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.67e-05 | 191 | 160 | 6 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-05 | 191 | 160 | 6 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.67e-05 | 191 | 160 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.67e-05 | 191 | 160 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-05 | 191 | 160 | 6 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.67e-05 | 191 | 160 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-05 | 191 | 160 | 6 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.67e-05 | 191 | 160 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.48e-05 | 195 | 160 | 6 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.69e-05 | 196 | 160 | 6 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Fos_(CA1_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.79e-05 | 63 | 160 | 4 | 22ab24281a42b60e79a6d35e25f42e7f20cb04b9 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.14e-05 | 198 | 160 | 6 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.14e-05 | 198 | 160 | 6 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 8.14e-05 | 198 | 160 | 6 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.14e-05 | 198 | 160 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-05 | 198 | 160 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.36e-05 | 199 | 160 | 6 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.36e-05 | 199 | 160 | 6 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 8.36e-05 | 199 | 160 | 6 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 8.36e-05 | 199 | 160 | 6 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 8.36e-05 | 199 | 160 | 6 | 3e14f9a62d6414add8d5f681be184b4625001838 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes|Lung / Manually curated celltypes from each tissue | 8.36e-05 | 199 | 160 | 6 | bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.36e-05 | 199 | 160 | 6 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.36e-05 | 199 | 160 | 6 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.36e-05 | 199 | 160 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 8.36e-05 | 199 | 160 | 6 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 8.36e-05 | 199 | 160 | 6 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.36e-05 | 199 | 160 | 6 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.36e-05 | 199 | 160 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.36e-05 | 199 | 160 | 6 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.60e-05 | 200 | 160 | 6 | 5f0f67958c9635db53e61f8370a92da6ea3e80fe | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.60e-05 | 200 | 160 | 6 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.60e-05 | 200 | 160 | 6 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Unfolded_protein_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 12078bc25be67180c0f4b37fef921cdcd1003576 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 8.60e-05 | 200 | 160 | 6 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.60e-05 | 200 | 160 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 8.60e-05 | 200 | 160 | 6 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 200 | 160 | 6 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.60e-05 | 200 | 160 | 6 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.60e-05 | 200 | 160 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.60e-05 | 200 | 160 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Computational | Placenta genes. | MAGEA4 HSPG2 VPS11 MYLK DHRS3 ITGA10 SRCAP DENND2B SLC4A2 SLC16A3 SLC18A3 MARF1 SLC23A2 | 3.34e-05 | 463 | 80 | 13 | MODULE_38 |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A | HSPG2 DHRS3 TICAM1 SLC2A3 ARHGEF10L PIK3IP1 NDRG1 SLC16A3 PML | 5.39e-06 | 186 | 155 | 9 | 2426_DN |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 5028_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 4704_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.30e-06 | 199 | 155 | 9 | 6795_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 3.09e-05 | 178 | 155 | 8 | 5234_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.06e-05 | 185 | 155 | 8 | 6243_UP | |
| Drug | 6-deoxy-6-bromoascorbic acid | 4.60e-05 | 2 | 155 | 2 | ctd:C068572 | |
| Drug | Prothanon | 4.60e-05 | 2 | 155 | 2 | CID000063031 | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; HL60; HT_HG-U133A | 4.73e-05 | 189 | 155 | 8 | 2508_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.91e-05 | 190 | 155 | 8 | 4362_DN | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.09e-05 | 191 | 155 | 8 | 7100_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 2922_DN | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 2437_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 2315_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 7092_UP | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 5461_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 3008_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 3399_DN | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6137_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6777_UP | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 5390_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 2251_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.80e-05 | 199 | 155 | 8 | 4725_DN | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 7.04e-05 | 200 | 155 | 8 | 6192_DN | |
| Disease | salivary gland cancer (implicated_via_orthology) | 2.53e-05 | 2 | 149 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | Transient hypothyroxinaemia of prematurity | 2.53e-05 | 2 | 149 | 2 | C3827793 | |
| Disease | X-24431 measurement | 7.57e-05 | 3 | 149 | 2 | EFO_0800882 | |
| Disease | carotid artery disease (is_marker_for) | 1.15e-04 | 19 | 149 | 3 | DOID:3407 (is_marker_for) | |
| Disease | phenylketonuria (implicated_via_orthology) | 1.51e-04 | 4 | 149 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | tartronate (hydroxymalonate) measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0800944 | |
| Disease | glia-derived nexin measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0020403 | |
| Disease | Thyroid Dyshormonogenesis 1 | 3.75e-04 | 6 | 149 | 2 | C1848805 | |
| Disease | extraversion measurement | 3.75e-04 | 6 | 149 | 2 | EFO_0007913 | |
| Disease | oxalate measurement | 5.62e-04 | 32 | 149 | 3 | EFO_0010517 | |
| Disease | multiple myeloma (is_marker_for) | 7.97e-04 | 36 | 149 | 3 | DOID:9538 (is_marker_for) | |
| Disease | post-operative acute kidney injury | 8.91e-04 | 9 | 149 | 2 | EFO_0009955 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 8.91e-04 | 9 | 149 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | synaptotagmin-11 measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0802108 | |
| Disease | threonate measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0021032 | |
| Disease | platelet crit | VMP1 VPS11 PGS1 FLT3 SKI DENND2B SIRPD SBNO1 KCND1 CD40LG PHLPP1 LINC02694 PDLIM2 | 1.12e-03 | 952 | 149 | 13 | EFO_0007985 |
| Disease | Malignant neoplasm of breast | MAGEA4 TFAP2D TICAM1 SPTLC1 CFP SERPINE2 LMF2 NDRG1 PER3 SLC16A3 SBNO1 SPOCD1 NOTCH2 TP73 | 1.12e-03 | 1074 | 149 | 14 | C0006142 |
| Disease | hepatocyte growth factor measurement | 1.44e-03 | 44 | 149 | 3 | EFO_0006903 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.74e-03 | 47 | 149 | 3 | C3179349 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 1.90e-03 | 13 | 149 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.90e-03 | 13 | 149 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Tumors | 2.08e-03 | 50 | 149 | 3 | C0238198 | |
| Disease | dystonia (is_implicated_in) | 2.21e-03 | 14 | 149 | 2 | DOID:543 (is_implicated_in) | |
| Disease | ascorbic acid 3-sulfate measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0800173 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.21e-03 | 14 | 149 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | Saldino-Noonan Syndrome | 2.21e-03 | 14 | 149 | 2 | C0036069 | |
| Disease | Glioblastoma Multiforme | 2.46e-03 | 111 | 149 | 4 | C1621958 | |
| Disease | glycerate measurement | 2.55e-03 | 15 | 149 | 2 | EFO_0021029 | |
| Disease | vitamin C measurement | 2.90e-03 | 16 | 149 | 2 | EFO_0600003 | |
| Disease | platelet-derived growth factor BB measurement | 3.67e-03 | 61 | 149 | 3 | EFO_0008264 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LATLVPPQASGCTFL | 686 | A9YTQ3 | |
| ETPGCATLLPASLFV | 251 | Q8WV16 | |
| AINAFLDCSVVLPPS | 601 | P04920 | |
| PGFQLSCCIPSTNLA | 351 | Q8IZF5 | |
| PVNCPLLGFSAVSTS | 806 | Q9HCE6 | |
| QEPSLGCSIPAILFL | 51 | O00585 | |
| PAAAPSCASGLLQTL | 126 | Q99626 | |
| QAPFIASLCLKSPGR | 186 | P29965 | |
| SAPCVPNGSALLLSN | 496 | Q08345 | |
| PRFISPASQVAICLA | 671 | Q14416 | |
| DLPSCGVIPFVQSLL | 61 | Q86UQ4 | |
| PSLLVLLVFPSSCLA | 6 | P19021 | |
| EPLPGQVCSTFTLCL | 126 | Q8TAP6 | |
| SVICTGSLTQPLFPC | 996 | Q9NR16 | |
| GSLTQPLFPCLANVS | 1001 | Q9NR16 | |
| AGVAACLPLAQSTPF | 126 | P78524 | |
| LLPSPLAVLTFTLCS | 416 | A4D256 | |
| PCFPTVTSLQDLASG | 221 | Q9P1Y5 | |
| LRNSFNTSPGVPCSL | 301 | Q49A88 | |
| NPTDLFCSVPGRLSL | 206 | Q7Z6R9 | |
| VQLQCLAHGTPPLTF | 3316 | P98160 | |
| SRESSALPLLFPCGN | 131 | P10746 | |
| LDSPLCTSLGFASPL | 1576 | Q9Y4B5 | |
| TGRLPCPSNTAALLA | 136 | P29074 | |
| LGVNFPLSFPNLCSC | 951 | Q9ULG1 | |
| PPGLLVAFSACTTVL | 91 | Q9BRQ5 | |
| SISPLSVLSCLFPGL | 1156 | Q9NRD9 | |
| GLVTCSIPDNLPFTL | 411 | Q9Y5G9 | |
| ASVPASQCVPFLISL | 646 | Q7RTW8 | |
| SPVICGPNRSFLSLK | 2081 | Q04721 | |
| FPPVLSLACTDTSIN | 181 | Q8NGY5 | |
| PLFALACISAPSTEL | 201 | Q8NGC7 | |
| TLRNSSLGTPCLFPE | 626 | Q9NSA2 | |
| QSVLISCAIAGDPFP | 736 | Q15746 | |
| PQGASALPTTISFTC | 66 | P43358 | |
| LCSTQSNPDPILTIF | 346 | P20916 | |
| LAAAGSPVFLCALSP | 151 | O15427 | |
| AFCSPNLLPLATVGA | 196 | Q86U10 | |
| RSPPAGCFFLSLLLA | 46 | Q8TDU6 | |
| PPLLLGQFCSNSSSI | 376 | Q8WXT5 | |
| PPPLLGQFCSNSSSI | 376 | Q6VB84 | |
| GSLPSSTCFLLLPLL | 161 | A0A0K2S4Q6 | |
| FSIPTCVLNGELPLR | 281 | Q9NY93 | |
| FVGLADTPSCAVLLP | 146 | Q8NA75 | |
| DTPSCAVLLPASLFI | 151 | Q8NA75 | |
| PPGLLIAFSACTTVL | 116 | Q96D31 | |
| TDGLPQCAPLTVLDF | 576 | Q9NRD8 | |
| AAALAASVPCGLSVP | 381 | P55316 | |
| LPCPFLGATASSAIS | 866 | P56645 | |
| PPVQSSLCCLQFTAL | 316 | P47883 | |
| SSLPCLTLIGSPNFG | 476 | Q32NB8 | |
| ALVPATLAFNLGCDP | 271 | Q13608 | |
| LQCPALLVVGDSSPA | 251 | Q92597 | |
| NCTIPLIFVLSPGAD | 2491 | Q6ZR08 | |
| FPSGDCPSAIALLAI | 126 | O60928 | |
| TSVPSVPLGSRQCFL | 456 | Q86UT5 | |
| CQPTPGLETLNLTTF | 71 | Q9BYR7 | |
| CQPTPGLETLNLTTF | 71 | Q9BYR6 | |
| PLFLLASVTLPSICS | 6 | P07093 | |
| LSPRQLLGFPCAEVS | 61 | Q13421 | |
| AICDITFPPGLSQLV | 446 | Q6NSJ5 | |
| TQSLPLSVLCPGAGL | 36 | Q9BTN0 | |
| TLPATGSDPVLCFTQ | 21 | P27918 | |
| ITLPLSAFTNPTCEI | 216 | Q96FE7 | |
| FLLDTSLEPPLCGQT | 316 | Q13219 | |
| PPLACALQAFSLGQR | 596 | Q8IZL8 | |
| INPLLSLSCTDPFTN | 181 | P47890 | |
| ACFSQPPTAAQLLRA | 31 | Q86UW1 | |
| AQGETPCLLSPALFQ | 321 | Q8IZE3 | |
| PSLVSFLTGLGCPNC | 491 | O15350 | |
| CSSTNPLFTAALGAP | 356 | Q8IUM7 | |
| PISEVILASQLPFCA | 156 | Q8NGY6 | |
| QPNPLFSCLCVSGAI | 136 | O95389 | |
| GTSCETILLNSPGPF | 521 | P36888 | |
| VFALASISSVPLCPL | 221 | Q1HG44 | |
| CSSQLSAPTFLRQGP | 1351 | Q711Q0 | |
| GISVPSGLFVPSLLC | 481 | P51797 | |
| ALPTCALGTTPVFDL | 51 | P83105 | |
| LQTSQPPFCLPASSL | 386 | Q9H5Z6 | |
| FSPSVLDLGPLLLCA | 1826 | Q4G0P3 | |
| TGSVCFPLNRPILAF | 186 | Q9Y366 | |
| STSLPPLVEGQLRCF | 26 | Q4AC94 | |
| ATLFPSGYLIPLTQC | 631 | A0AVK6 | |
| PGSLLPAQVAACAQT | 131 | P49716 | |
| QLFPAPLLAGVTATC | 36 | Q92847 | |
| AFSPGLPPQSCSLNL | 241 | Q8N6M3 | |
| VRGFLLPNLPCVFSS | 91 | Q9H9V9 | |
| FVTLSCNASGLPVPV | 421 | Q4KMG0 | |
| PLVICSGISNQPLEF | 661 | A8MPP1 | |
| TTLLVNPTSFPCPLN | 1181 | Q3T8J9 | |
| VCSPTPFLIGILSCS | 736 | Q68D51 | |
| PSCLPGTLLNTATYA | 151 | A6NNA5 | |
| CLLPSSQARQSPLGS | 936 | Q9Y4F3 | |
| LPLVFLTGLCSPFNL | 11 | O75578 | |
| QRPALLICTAAAGPT | 681 | Q8IXH8 | |
| ACPFVPLLSVQTLDS | 1191 | O75064 | |
| TILPAILQSAALPFC | 191 | P11169 | |
| SLQQELCPSFLLPSA | 161 | Q53GD3 | |
| IPLQSAATLGVNPCT | 156 | Q9BV79 | |
| ISNPVSGLFLLCSPT | 81 | Q1W209 | |
| QISQPICLGPLFFSR | 766 | P51530 | |
| NIAALSLVPGCSPSI | 976 | Q9Y467 | |
| PANCVSPLVNLLSTS | 1351 | A3KN83 | |
| LNSLVGPACIFLRPS | 51 | Q9NPB3 | |
| LLDCPGVSATTVLPF | 206 | O75911 | |
| PLLCLSQSGPPSFLQ | 516 | Q9HB75 | |
| VQIFLALSLPFCGPN | 156 | Q8NGL9 | |
| LLSPQQTISIPGCAA | 86 | P0C629 | |
| CLRQTLPLSFVFGPE | 1736 | Q5T011 | |
| GALTTCNIPLAFLEP | 296 | Q16572 | |
| PLSVSFSAGCVALPA | 281 | Q9H871 | |
| NCSFSTPVPLSLGKL | 436 | Q99932 | |
| LPFNAPSCGLITLTD | 211 | P12757 | |
| ICGPSFDIASIIPFL | 866 | Q969F9 | |
| FVQALLAPCSLRSSP | 651 | Q9BU23 | |
| QPAPLLCSVLKASGS | 601 | Q15345 | |
| CLLPTGLPVRSVDFN | 21 | Q13449 | |
| TFTTVPCLCLLGPNL | 121 | Q07326 | |
| PLAAVPSNLTCTLFR | 811 | Q96NR3 | |
| PFSSLQCFASLQPLV | 771 | P29590 | |
| PPLLLGQFCSNSSSI | 376 | Q5VV16 | |
| PPPLLGQFCSNSSSI | 376 | Q3SYB3 | |
| SQALLTPVALDFPCL | 936 | O15197 | |
| CGDPFSVDLILSPFL | 786 | Q13017 | |
| ASLLAICPFPSEALS | 626 | Q6P9B9 | |
| FVPLTSICFPDSLLQ | 926 | Q9ULL5 | |
| GLNSTVAPACSPVLV | 1536 | Q6ZRS2 | |
| CTGFFLSLLPKSTPN | 31 | Q9HD33 | |
| LFPTILISQLPFCGS | 156 | Q8NGC5 | |
| ISRSFQSLACSPGLP | 151 | Q96JY6 | |
| ILPFSAPSCGLITKT | 166 | P12755 | |
| NGALPLNLTCTVSPS | 176 | Q99884 | |
| CFSASLPPLLAAAAI | 336 | O15269 | |
| FLQSCPPIITFVASI | 521 | Q8IXR9 | |
| LAQARAALCGTPTPS | 81 | A5D8T8 | |
| LAQARAALCGIPTPS | 81 | Q6UXF7 | |
| LAQARAALCGIPTPS | 81 | Q8NCF0 | |
| QQPLSVTCFSLALPS | 696 | Q6ZRI6 | |
| CQSLLSDPLGVTFPT | 161 | Q8NAA6 | |
| GSAASKFLCLPPGIT | 36 | Q9H270 | |
| VLAGTACLFTPLALP | 86 | P17152 | |
| NGCIPLVDPFASESL | 66 | A6NFC5 | |
| GCLEFPASSLPVLQF | 371 | O14924 | |
| CGITNLLAPLATTFP | 376 | O15374 | |
| SLPDPVLGALFCTLF | 481 | Q9UGH3 | |
| CLAFILDNTVPGSPE | 506 | Q9UHI7 | |
| RTLQSNLGCLPPSSA | 156 | Q8IUC6 | |
| PLVCATGLLGSAPFL | 356 | Q9H2V7 | |
| ALPTVIRSAGCIPSN | 896 | Q6ZMY3 | |
| ILCAAFLPPQTLVTG | 286 | Q8IV35 | |
| VFCSPLVPGQSHLQL | 251 | Q8IV45 | |
| LQFPLTFSGTVRPIC | 296 | Q9NRS4 | |
| LACSLFVQVGTPLSP | 111 | A8MV23 | |
| SIILSCSVPNTLPNG | 46 | Q9H106 | |
| CNDGLLESFPAVLPS | 836 | Q68DE3 | |
| STLCLPSVGAARPQV | 551 | A8MT19 | |
| CLRVFGTLLQPVTPS | 516 | Q96GW9 | |
| PLAGCQTLLSPIVSC | 491 | Q6ZN44 | |
| LALLRPSCAFGPNTI | 286 | Q7RTY5 | |
| FPCPLNQPLVASSVS | 646 | Q9H869 | |
| PPVLLQGSCSASAVA | 366 | Q6ZSS3 | |
| FPLAVCSIPTLAELN | 706 | O60346 | |
| QASPGASSFLTCPEL | 51 | Q6AWC8 | |
| PRILSLACSPNGASF | 496 | A4D1P6 | |
| LACASIPNPLFDLAG | 261 | Q96GC9 | |
| TAALIIACFPTISPF | 351 | Q8NFZ6 |